Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3692371016 | Ursodiol 50 mg/mL oral suspension | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 3692373018 | Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3692374012 | Ursodeoxycholic acid 50 mg/mL oral suspension | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension | Has manufactured dose form | Conventional release oral suspension | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension | Is a | Product containing ursodeoxycholic acid in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension | Has precise active ingredient | Ursodeoxycholic acid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension | Has basis of strength substance | Ursodeoxycholic acid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension | Has concentration strength numerator value | 50 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension | Is a | Product containing only ursodeoxycholic acid in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR